3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2/3
1
Phase 2
1
Status
Unknown
2
Withdrawn
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
6
Carcinoma, Hepatocellular
5
Head and Neck Neoplasms
4
Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Neoplasms, Squamous Cell
2
Glioblastoma
2
Colonic Neoplasms
2
Uterine Cervical Neoplasms
1
Urinary Incontinence
1
Tuberous Sclerosis
1
Sarcoma
1
Recurrent respiratory papillomatosis
1
Recurrence
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Postoperative Complications
1
Papillomavirus Infections
1
Papilloma
1
Ovarian Neoplasms
1
Orgasm
1
Oligodendroglioma
1
Neoplasms
1
Neoplasm Metastasis
1
Myasthenia Gravis
1
Melanoma
1
Medication Adherence
1
Interventions
Everolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Withdrawn
×
Tuberous Sclerosis
×
Clear all
NCT02860494
2021-05-03
EVEROST
Hospices Civils de Lyon
Phase 2/3
Withdrawn